Investors eye downtown Durham for residential, life sciences project after $62M deal
Investors eye downtown Durham for residential, life sciences project after $62M deal
A group of real estate investors could revitalize an aging retail center in downtown Durham by turning it into a life sciences and residential development.
You can contact us to get more choices
0
You can contact us to get more choices
Related posts
A group of real estate investors could revitalize an aging retail center in downtown Durham by turning it into a life sciences and residential development.
A group of real estate investors could revitalize an aging retail center in downtown Durham by turning it into a life sciences and residential development.
A joint venture between Harrison Street, an investment management firm, national developer Sterling Bay, and real estate firm Acram Group is planning to transform the nearly 10-acre downtown site.
A joint venture between Harrison Street, an investment management firm, national developer Sterling Bay, and real estate firm Acram Group is planning to transform the nearly 10-acre downtown site.
In 2021, the life sciences sector had one of its best years on record. Already growing rapidly before the pandemic hit, the race to develop vaccines helped further bolster the niche sector, leading to a record number of IPOs formed last year. But 2022 has been different. The COVID-19 boost the industry benefited from has ended, and numbers are coming back down to Earth, looking more like they did pre-pandemic. Investment activity and venture capital funding have dropped significantly, and overal...
In 2021, the life sciences sector had one of its best years on record. Already growing rapidly before the pandemic hit, the race to develop vaccines helped further bolster the niche sector, leading to a record number of IPOs formed last year. But 2022 has been different. The COVID-19 boost the industry benefited from has ended, and numbers are coming back down to Earth, looking more like they did pre-pandemic. Investment activity and venture capital funding have dropped significantly, and overal...
Dive Brief:
Boston-based Suffolk Construction has begun turning a former industrial building into a high-tech life sciences facility in an effort to help address the space shortage in New York Cityβs biotech industry, according to a press release shared with Construction Dive.
The gut renovation and redevelopment of the 218,000-square-foot, seven-story lab and research center at 43-10 23rd St. in Long Island City, Queens, New York, will feature class A lab space that includes flexible floor p...
Dive Brief:
Boston-based Suffolk Construction has begun turning a former industrial building into a high-tech life sciences facility in an effort to help address the space shortage in New York Cityβs biotech industry, according to a press release shared with Construction Dive.
The gut renovation and redevelopment of the 218,000-square-foot, seven-story lab and research center at 43-10 23rd St. in Long Island City, Queens, New York, will feature class A lab space that includes flexible floor p...
Blackstone's subdivision will soon double its portfolio in the local market.
The post BioMed Realty Pays $127M for Seattle Life Sciences Site appeared first on Commercial Property Executive.
Blackstone's subdivision will soon double its portfolio in the local market.
The post BioMed Realty Pays $127M for Seattle Life Sciences Site appeared first on Commercial Property Executive.
Consider these factor when determining which direction to pursue, says Justin Brasell and David Klein of Transwestern.
The post Adaptive Reuse or New Construction? Considerations for Life Sciences appeared first on Commercial Property Executive.
Consider these factor when determining which direction to pursue, says Justin Brasell and David Klein of Transwestern.
The post Adaptive Reuse or New Construction? Considerations for Life Sciences appeared first on Commercial Property Executive.
The project known as the Refinery will create 121,000 sq ft of high spec, laboratory, research and development spaces under one roof. Located on the Northern Embankment of the River Thames, the project will include the extension and full reconfiguration of the existing four-storey building. Its façade and roof will be replaced, two new storeys added, and a green roof will finish the look of the building. During the project, Kier will support local small and medium enterprises (SMEs) through t...
The project known as the Refinery will create 121,000 sq ft of high spec, laboratory, research and development spaces under one roof. Located on the Northern Embankment of the River Thames, the project will include the extension and full reconfiguration of the existing four-storey building. Its façade and roof will be replaced, two new storeys added, and a green roof will finish the look of the building. During the project, Kier will support local small and medium enterprises (SMEs) through t...
Guyβs & St Thomasβ Foundation selects developer for Snowsfields Quarter biosciences hub
Guyβs & St Thomasβ Foundation selects developer for Snowsfields Quarter biosciences hub
Texas Medical Center Announces TMC BioPort campus The Texas Medical Center announced plans for a 4th campus a massive biomanufacturing and medical supplies distribution center in Houston. TMC BioPort will be built on 500 acres south of Loop 610. The newest campus is still in the early stages of development. However, once completed, itβs expected to double the overall size of the medical center and create 100,000 jobs for the Greater Houston metro, TMC President and CEO Bill McKeon said during ...
Texas Medical Center Announces TMC BioPort campus The Texas Medical Center announced plans for a 4th campus a massive biomanufacturing and medical supplies distribution center in Houston. TMC BioPort will be built on 500 acres south of Loop 610. The newest campus is still in the early stages of development. However, once completed, itβs expected to double the overall size of the medical center and create 100,000 jobs for the Greater Houston metro, TMC President and CEO Bill McKeon said during ...
Even before the pandemic, demand for life sciences had been building for almost 20 years. In 2020, pharma, R&D, and medical technology raced to procure vital medical products and solutions to develop new therapies and vaccines for COVID-19, which may have been the tipping point that led to the life sciences boom.
In 2021, a record $78 billion of private equity and public investments was pumped into life science-related companies, up from $70 billion the year prior.Β Key life science...
Even before the pandemic, demand for life sciences had been building for almost 20 years. In 2020, pharma, R&D, and medical technology raced to procure vital medical products and solutions to develop new therapies and vaccines for COVID-19, which may have been the tipping point that led to the life sciences boom.
In 2021, a record $78 billion of private equity and public investments was pumped into life science-related companies, up from $70 billion the year prior.Β Key life science...